Osteoarthritis is a chronic inflammatory joint disease characterized by cartilage degradation, synovial inflammation, and subchondral bone remodeling, and its development may be influenced by multiple factors such as genetics, environment, metabolism, and mechanical stress, with a complex pathogenesis. Clinically, osteoarthritis seriously affects the life of patients with clinical manifestations such as pain, swelling, and joint movement disorders. With the aggravation of the aging population in China, patients with osteoarthritis are on the rise. Therefore, the study of OA pathological mechanism has drawn much more concerns. Pyroptosis is a proinflammatory programmed cell necrosis mediated by inflammasomes that depends on Gasdermin family proteins and it is closely related to the development and progression of a variety of diseases. Statistics showed that pyroptosis plays an important role in the development and progression of osteoarthritis. By reviewing the latest research on the molecular mechanism of pyroptosis and its effect in treating osteoarthritis, the important role of pyroptosis activation pathway in the process of osteoarthritis is revealed, focusing on the related signaling molecules, signaling pathways, targets of pyroptosis, and targeted drugs that inhibit pyroptosis. It provides new ideas for the mechanism study of osteoarthritis and also new targets for the treatment of osteoarthritis.
Published in | International Journal of Clinical and Experimental Medical Sciences (Volume 8, Issue 5) |
DOI | 10.11648/j.ijcems.20220805.14 |
Page(s) | 73-77 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Pyroptosis, Osteoarthritis, Caspase-1, NLRP3, Gasdermin-D, IL-1β
[1] | Hawker, G A. Osteoarthritis is a serious disease. Clin Exp Rheu matol, 2019, 37 Suppl 120 (5): 3-6. |
[2] | Price C C, Tanner J J, SCHMALFUSS I, et al. A pilot study evaluating presurgery neuroanatomical biomarkers for postoperative cognitive decline after total knee arthroplasty in older-adults. Anesthesiology, 2014, 120 (3): 601-613. |
[3] | Tie X J, Zheng R G, et al. Meta-analysis of prevalence of knee osteoarthritis in middle-aged and elderly Chinese. China Tissue Engineering Research, 2018, 22 (4): 650-656. |
[4] | Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol, 2014, 28 (1): 5-15. |
[5] | Iwamoto M, Ohta Y, Larmour C, et al. Toward regeneration of articular cartilage. Birth Defects Res C Embryo Today, 2013, 99: 192-202. |
[6] | Smith MD. The normal synovium. Open Rheumatol J, 2011, 5: 100-6. |
[7] | Lopes EBP, Filiberti A, Husain SA, et al. Immune contributions to osteoarthritis. Curr Osteoporos Rep, 2017, 15: 593-600. |
[8] | GALLUZZI L, VITALE I, AARONSON SA, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018; 25 (3): 486-541. |
[9] | Vande Walle L, Lamkanfi M. Pyroptosis. Curr Biol, 2016; 26: R568-R572. |
[10] | ZHOU XuChang, et al. Progress in the mechanism of pyrolysis in osteoarthritis. 2022, 04-0401-08. |
[11] | Senbo An, Huiyu Hu. et al. Pyroptosis Plays a Role in Osteoarthritis. Aging Dis. 2020; 11 (5): 1146-1157. |
[12] | ZYCHLINSKY, A, PREVOST, MC, SANSONETTI PJ. Shigella flexneri induces apoptosis in infected macrophages. Nature. 1992; 358 (6382): 167-169. |
[13] | COOKSON BT, BRENNAN MA. Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9 (3): 113-114. |
[14] | SHI J, ZHAO Y, WANG K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015; 526 (7575): 660-665. |
[15] | Xia X, Wang X, Zheng Y, et al. What role does pyroptosis play in microbial infection? J Cell Physiol, 2019, 234: 7885-92. |
[16] | XIA S, HOLLINGSWORTH LRT, WU H. Mechanism and Regulation of GasderminMediated Cell Death. Cold Spring Harb Perspect Biol. 2020; 12 (3): 31451512. |
[17] | Zhao LR, Xing RL, Wang PM, et al. NLRP1 and NLRP3 inflflammasomes mediate LPS/ATP-induced pyroptosis in knee osteoarthritis. Mol Med Rep, 2018, 17: 5463-9. |
[18] | Swanson KV, Deng M, Ting JP. The NLRP3 inflflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol, 2019, 19: 477-89. |
[19] | Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev, 2017, 277: 61-75. |
[20] | Feng S, Fox D, Man SM. Mechanisms of gasdermin family members in inflammasome signaling and cell death. J Mol Biol, 2018, 430: 3068-80. |
[21] | An S, Hu H, Li Y, et al. Pyroptosis plays a role in osteoarthritis. Aging Dis, 2020, 11: 1146-57. |
[22] | Kayagaki N, Stowe IB, Lee BL, et al. Caspase-11 cleaves gasdermin-D for non-canonical inflammasome signalling. Nature, 2015, 526: 666-71. |
[23] | Jorgensen I, Rayamajhi M, Miao EA. Programmed cell death as a defense against infection. Nat Rev Immunol, 2017. 17: 15l-164. |
[24] | Doitsh G, Galloway NL, Geng X, et a1. Cell death by Pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature, 2014, 505: 509-514. |
[25] | Rheinheimer J, de Souza BM, Card OSO NS, et a1. Current role of the NLRP3 inflammasome on obesity and insulin resistanee: A systematic review. Metabolism, 2017, 74: 1-26 9. |
[26] | Henao Mejia J, Elinav E, Thaiss CA, Flavell RA. Inflammasomes and metabolic disease. Annu Rev Physiol, 2014 76: 57-78. |
[27] | Jiang D, Chen S, Sun R, et al. The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways. Cancer Lett, 2018, 419: 8-19. |
[28] | Hu Nicotinic acetylcholine receptor mediated antiinflammatory actions modulate brain functions. Neurotransmitter, 2016, 3: e1303. |
[29] | Altaf A, Qn P, Zhao Y, et al. NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins. Coron Artery Dis, 2 015. 26: 409-421. |
[30] | Zhang YN, Xie BD, Sun L, Chen W, Jiang SL, Liu W, et al. Phenotypic switching of vascular smooth muscle cells in the ’normal region’ of aorta from atherosclerosis patients is regulated by miR-145. J Cell Mol Med,. 2016, 20: 1049-1061. |
[31] | Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C, et al, NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS One, 2014, 9: e104771. |
[32] | Soliman EZ, Prineas RJ, Antihypertensive Therapies and Left Ventricular Hypertrophy. Curr Hypertens Rep, 2017. 19: 79. |
[33] | Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia reperfusion injury. Circulation, 2011. 123: 594-604. |
[34] | Zheng Y, Gardner SE, Clarke MC. Cell death, damage-associated molecular patterns, and sterile inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol, 2011. 31: 2781-2786. |
[35] | Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carle B, et al. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation. Gastroenterology, 2019.156: 1082-1097.e1011. |
[36] | Hanson B. Necroptosis: A new way of dying? Cancer Biol Ther, 2016. 17: 899-910. |
[37] | Magna M, Pisetsky DS. The Role of Cell Death in the Pathogenesis of SLE: Is Pyroptosis the Missing Link? Scand J Immunol, 2015. 82: 218-224. |
[38] | Gao YL, Zhai JH, Chai YF. Recent Advances in the Molecular Mechanisms Underlying Pyroptosis in Sepsis. Mediators Inflamm, 2018: 5823823. |
[39] | Mathews RJ, Robinson JI, Battellino M, Wong C, Taylor JC, Eyre S, et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis,. 2014. 73: 1202-1210. |
[40] | BAI Z, LIU W, HE D, et al. Protective effects of autophagy and NFE2L2 on reactive oxygen species-induced pyroptosis of human nucleus pulposus cells. Aging. 2020; 12 (8): 7534-7548. |
[41] | YUAN fang, et al. Mechanisms of chondrocyte apoptosis in osteoarthritis. Journal of Practical Medicine, 2015, 31 (4): 666-668. |
[42] | BOILEAu C, et al. The in situ up regulation of chond IDcyte interleukin-1 converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide. Arhritis Rheum, 2002, 46 (10): 2637-2647. |
[43] | Gupta N, Sahu A, Prabhakar A, et al. Activation of NLRP3 inflammasome complex potentiates venous thrombosis in response to hypoxia. Proc Natl Acad Sci U S A, 2017, 114: 4763-8. |
[44] | Liu Q, Wu Z, Hu D, et al. Low dose of indomethacin and Hedgehog signaling inhibitor administration synergistically attenuates cartilage damage in osteoarthritis by controlling chondrocytes pyroptosis. Gene, 2019, 712: 143959. |
[45] | He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci, 2016, 41: 1012-21. |
[46] | Hu J, Zhou J, Wu J, et al. Loganin ameliorates cartilage degeneration and osteoarthritis development in an osteoarthritis mouse model through inhibition of NF-κB activity and pyroptosis in chondrocytes. J Ethnopharmacol, 2020, 247: 112261. |
[47] | Yu H, Yao S, Zhou C, et al. Morroniside attenuates apoptosis and pyroptosis of chondrocytes and ameliorates osteoarthritic development by inhibiting NF-κB signaling. J Ethnopharmacol, 2021, 266: 113447. |
[48] | Zu Y, Mu Y, Li Q, et al. Icariin alleviates osteoarthritis by inhibiting NLRP3-mediated pyroptosis. J Orthop Surg Res, 2019, 14: 307. |
[49] | Yan Z, Qi W, Zhan J, et al. Activating Nrf2 signalling alleviates osteoarthritis development by inhibiting inflammasome activation. J Cell Mol Med, 2020, 24: 13046-57. |
[50] | YANG yang et al. Mechanism of Guizhi Fuzi Decoction on inhibiting chondrocytes pyroptosis by regulating TXNIP/NLRP3/caspase-1 pathw Loganin ameliorates cartilage degeneration and osteoarthritis development in an osteoarthritis mouse model through inhibition of NF-κB activity and pyroptosis in chondrocytes, Modern Practical Medicine, 2021 06-0709-04. |
[51] | Li Z, Huang Z, Zhang H, et al. P2X7 receptor induces pyroptotic inflammation and cartilage degradation in osteoarthritis via NF-κB/NLRP3 crosstalk. Oxid Med Cell Longev, 2021, 2021: 8868361. |
[52] | Chen Z, Zhong H, Wei J, et al. Inhibition of Nrf2/HO-1 signaling leads to increased activation of the NLRP3 inflammasome in osteoarthritis. Arthritis Res Ther, 2019, 21: 300. |
[53] | Zhang L, Zhang L, Huang Z, et al. Increased HIF-1α in knee osteoarthritis aggravate synovial fibrosis via fibroblastlike synoviocyte pyroptosis. Oxid Med Cell Longev, 2019, 2019: 6326517. |
[54] | WANG Tiantian, et al. Mechanism of moxibustion down-regulating p38 MAPK signaling pathway inhibiting chondrocyte pyroptosis and improving knee osteoarthritis in rats. |
[55] | Yao Zhang 1, Zihao Lin, et al CY-09 attenuates the progression of osteoarthritis via inhibiting Biochemical and Biophysical Research Communications 2021; 553: 119-125. |
[56] | Shuya Wang, Ali Mobasheri, et al Exogenous stromal cell-derived factor-1 (SDF-1) suppresses the NLRP3 inflammasome and inhibits pyroptosis in synoviocytes from osteoarthritic joints via activation of the AMPK signaling pathway, Inflammopharmacology 2021 (3): 695-704. |
APA Style
Xiaosheng Chen, Zhenyu Yang, Qingqi Meng, Siming Li. (2022). Role of Pyroptosis in Osteoarthritis and Its Therapeutic Significance. International Journal of Clinical and Experimental Medical Sciences, 8(5), 73-77. https://doi.org/10.11648/j.ijcems.20220805.14
ACS Style
Xiaosheng Chen; Zhenyu Yang; Qingqi Meng; Siming Li. Role of Pyroptosis in Osteoarthritis and Its Therapeutic Significance. Int. J. Clin. Exp. Med. Sci. 2022, 8(5), 73-77. doi: 10.11648/j.ijcems.20220805.14
@article{10.11648/j.ijcems.20220805.14, author = {Xiaosheng Chen and Zhenyu Yang and Qingqi Meng and Siming Li}, title = {Role of Pyroptosis in Osteoarthritis and Its Therapeutic Significance}, journal = {International Journal of Clinical and Experimental Medical Sciences}, volume = {8}, number = {5}, pages = {73-77}, doi = {10.11648/j.ijcems.20220805.14}, url = {https://doi.org/10.11648/j.ijcems.20220805.14}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20220805.14}, abstract = {Osteoarthritis is a chronic inflammatory joint disease characterized by cartilage degradation, synovial inflammation, and subchondral bone remodeling, and its development may be influenced by multiple factors such as genetics, environment, metabolism, and mechanical stress, with a complex pathogenesis. Clinically, osteoarthritis seriously affects the life of patients with clinical manifestations such as pain, swelling, and joint movement disorders. With the aggravation of the aging population in China, patients with osteoarthritis are on the rise. Therefore, the study of OA pathological mechanism has drawn much more concerns. Pyroptosis is a proinflammatory programmed cell necrosis mediated by inflammasomes that depends on Gasdermin family proteins and it is closely related to the development and progression of a variety of diseases. Statistics showed that pyroptosis plays an important role in the development and progression of osteoarthritis. By reviewing the latest research on the molecular mechanism of pyroptosis and its effect in treating osteoarthritis, the important role of pyroptosis activation pathway in the process of osteoarthritis is revealed, focusing on the related signaling molecules, signaling pathways, targets of pyroptosis, and targeted drugs that inhibit pyroptosis. It provides new ideas for the mechanism study of osteoarthritis and also new targets for the treatment of osteoarthritis.}, year = {2022} }
TY - JOUR T1 - Role of Pyroptosis in Osteoarthritis and Its Therapeutic Significance AU - Xiaosheng Chen AU - Zhenyu Yang AU - Qingqi Meng AU - Siming Li Y1 - 2022/09/27 PY - 2022 N1 - https://doi.org/10.11648/j.ijcems.20220805.14 DO - 10.11648/j.ijcems.20220805.14 T2 - International Journal of Clinical and Experimental Medical Sciences JF - International Journal of Clinical and Experimental Medical Sciences JO - International Journal of Clinical and Experimental Medical Sciences SP - 73 EP - 77 PB - Science Publishing Group SN - 2469-8032 UR - https://doi.org/10.11648/j.ijcems.20220805.14 AB - Osteoarthritis is a chronic inflammatory joint disease characterized by cartilage degradation, synovial inflammation, and subchondral bone remodeling, and its development may be influenced by multiple factors such as genetics, environment, metabolism, and mechanical stress, with a complex pathogenesis. Clinically, osteoarthritis seriously affects the life of patients with clinical manifestations such as pain, swelling, and joint movement disorders. With the aggravation of the aging population in China, patients with osteoarthritis are on the rise. Therefore, the study of OA pathological mechanism has drawn much more concerns. Pyroptosis is a proinflammatory programmed cell necrosis mediated by inflammasomes that depends on Gasdermin family proteins and it is closely related to the development and progression of a variety of diseases. Statistics showed that pyroptosis plays an important role in the development and progression of osteoarthritis. By reviewing the latest research on the molecular mechanism of pyroptosis and its effect in treating osteoarthritis, the important role of pyroptosis activation pathway in the process of osteoarthritis is revealed, focusing on the related signaling molecules, signaling pathways, targets of pyroptosis, and targeted drugs that inhibit pyroptosis. It provides new ideas for the mechanism study of osteoarthritis and also new targets for the treatment of osteoarthritis. VL - 8 IS - 5 ER -